Appointments to the Boards of Directors 01 | 01
Le Grand-Quevilly, December 30, 2022
The Board of Directors of the UbiPharm Group has appointed on October 28, 2022, Mrs. NTSAME OBAME Solange as the new Chairman of the Board of Directors (PCA) of the company, replacing Mr. NDOUMOU OBAME Daniel.
New PCA in Cameroon, Gabon and Niger
The subsidiaries UbiPharm Cameroon, UbiPharm Gabon, and UbiPharm Niger have appointed a new Chairman of the Board of Directors of their respective companies.
- Mr. KINGUE IBOHN Richard, PCA UbiPharm Cameroon, effective October 22, 2022
- Mrs. MAHAMANE Monique, CEO of UbiPharm Niger, effective September 24, 2022
- Ms. NTSAME OBAME Solange also becomes the new PCA of Gesca, the Group's audit and control subsidiary, and of UbiPharm Gabon.
The mandate of the new PCA is for a period of 2 years, in accordance with the rotating presidency mode in force within the UbiPharm Group.
The UbiPharm group warmly thanks the outgoing chairmen for their leadership.
About the UbiPharm Group
Present in 15 African countries and 4 French overseas territories, UbiPharm promotes access to healthcare solutions. This supply chain expert integrates five business lines: wholesaler-distributor, distributor, logistician, promoter and distributor. With an innovative model based on 3,800 pharmacist-customer-shareholders and a high-performance and responsible distribution system, UbiPharm is proud to support healthcare players by creating close relationships that benefit everyone.
Health at hand, now.
For more information, please visit: www.ubipharm.com